Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells

References

• Aguzzi A, Glatzel M, Montrasio F, Prinz M, Heppner FL. Interventional strategies against prion diseases. Nat Rev Neurosci 2001; 2:745 - 749
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 348
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673 - 728
   PubMed Web of Science ®Google Scholar
• Weissmann C, Flechsig E. PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 2003; 66:43 - 60
   PubMed Web of Science ®Google Scholar
• Biasini E, Massignan T, Fioriti L, Rossi V, Dossena S, Salmona M, et al. Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity. Proteomics 2006; 6:2823 - 2834
   PubMed Web of Science ®Google Scholar
• Chich JF, Schaeffer B, Bouin AP, Mouthon F, Labas V, Larramendy C, et al. Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug. Biochim Biophys Acta 2007; 1774:154 - 167
   PubMed Web of Science ®Google Scholar
• Ramljak S, Asif AR, Armstrong VW, Wrede A, Groschup MH, Buschmann A, et al. Physiological role of the cellular prion protein (PrPC): protein profiling study in two cell culture systems. J Proteome Res 2008; 7:2681 - 2695
   PubMed Web of Science ®Google Scholar
• Massignan T, Biasini E, Lauranzano E, Veglianese P, Pignataro M, Fioriti L, et al. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway. Mol Cell Proteomics 2010; 9:611 - 622
   PubMed Web of Science ®Google Scholar
• Fasano C, Campana V, Griffiths B, Kelly G, Schiavo G, Zurzolo C. Gene expression profile of quinacrine-cured prion-infected mouse neuronal cells. J Neurochem 2008; 105:239 - 250
   PubMed Web of Science ®Google Scholar
• Greenwood AD, Horsch M, Stengel A, Vorberg I, Lutzny G, Maas E, et al. Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. J Mol Biol 2005; 349:487 - 500
   PubMed Web of Science ®Google Scholar
• Satoh J, Kuroda Y, Katamine S. Gene expression profile in prion protein-deficient fibroblasts in culture. Am J Pathol 2000; 157:59 - 68
   PubMed Web of Science ®Google Scholar
• Satoh J, Yamamura T. Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol 2004; 24:793 - 814
   PubMed Web of Science ®Google Scholar
• Windl O, Lorenz H, Behrens C, Romer A, Kretzschmar HA. Construction and characterization of murine neuroblastoma cell clones allowing inducible and high expression of the prion protein. J Gen Virol 1999; 80:15 - 21
   PubMed Web of Science ®Google Scholar
• Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, Grassi J, et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 2000; 74:320 - 325
   PubMed Web of Science ®Google Scholar
• Roche S, Delorme B, Oostendorp RA, Barbet R, Caton D, Noel D, et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 2009; 9:223 - 232
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68:850 - 858
   PubMed Web of Science ®Google Scholar
• Kim S, Lee YZ, Kim YS, Bahk YY. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K- and N-Ras) in NIH/3T3 mouse embryonic fibroblasts. Proteomics 2008; 8:3082 - 3093
   PubMed Web of Science ®Google Scholar
• Forloni G, Iussich S, Awan T, Colombo L, Angeretti N, Girola L, et al. Tetracyclines affect prion infectivity. Proc Natl Acad Sci USA 2002; 99:10849 - 10854
   PubMed Web of Science ®Google Scholar
• Petrak J, Ivanek R, Toman O, Cmejla R, Cmejlova J, Vyoral D, et al. Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008; 8:1744 - 1749
   PubMed Web of Science ®Google Scholar
• Wang H, Hanash S. Electrospray mass spectrometry for quantitative plasma proteome analysis. Methods Mol Biol 2009; 564:227 - 242
   PubMedGoogle Scholar
• Crecelius AC, Helmstetter D, Strangmann J, Mitteregger G, Frohlich T, Arnold GJ, et al. The brain proteome profile is highly conserved between Prnp−/− and Prnp+/+ mice. Neuroreport 2008; 19:1027 - 1031
   PubMed Web of Science ®Google Scholar
• Moore RA, Timmes A, Wilmarth PA, Priola SA. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Proteomics 2010; 10:2858 - 2869
   PubMed Web of Science ®Google Scholar
• Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, Lehnert S, et al. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Proteomics 2008; 8:4357 - 4366
   PubMed Web of Science ®Google Scholar
• Huzarewich RL, Siemens CG, Booth SA. Application of “omics” to prion biomarker discovery. J Biomed Biotechnol 2010; 2010:613504
   PubMed Web of Science ®Google Scholar
• Strom A, Diecke S, Hunsmann G, Stuke AW. Identification of prion protein binding proteins by combined use of far-western immunoblotting, two dimensional gel electrophoresis and mass spectrometry. Proteomics 2006; 6:26 - 34
   PubMed Web of Science ®Google Scholar
• Petrakis S, Sklaviadis T. Identification of proteins with high affinity for refolded and native PrPC. Proteomics 2006; 6:6476 - 6484
   PubMed Web of Science ®Google Scholar
• Giorgi A, Di Francesco L, Principe S, Mignogna G, Sennels L, Mancone C, et al. Proteomic profiling of PrP27–30-enriched preparations extracted from the brain of hamsters with experimental scrapie. Proteomics 2009; 9:3802 - 3814
   PubMed Web of Science ®Google Scholar
• Julius C, Hutter G, Wagner U, Seeger H, Kana V, Kranich J, et al. Transcriptional stability of cultured cells upon prion infection. J Mol Biol 2008; 375:1222 - 1233
   PubMed Web of Science ®Google Scholar
• Tang Y, Xiang W, Hawkins SA, Kretzschmar HA, Windl O. Transcriptional changes in the brain of cattle orally infected with BSE precede detection of infectivity. J Virol 2009; 83:9464 - 9473
   PubMed Web of Science ®Google Scholar
• Tatzelt J, Zuo J, Voellmy R, Scott M, Hartl U, Prusiner SB, et al. Scrapie prions selectively modify the stress response in neuroblastoma cells. Proc Natl Acad Sci USA 1995; 92:2944 - 2948
   PubMed Web of Science ®Google Scholar
• True HL. The battle of the fold: chaperones take on prions. Trends Genet 2006; 22:110 - 117
   PubMed Web of Science ®Google Scholar
• Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005; 25:2793 - 2802
   PubMed Web of Science ®Google Scholar
• Wacker JL, Huang SY, Steele AD, Aron R, Lotz GP, Nguyen Q, et al. Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease. J Neurosci 2009; 29:9104 - 9114
   PubMed Web of Science ®Google Scholar
• Kristiansen M, Messenger MJ, Klohn PC, Brandner S, Wadsworth JD, Collinge J, et al. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem 2005; 280:38851 - 38861
   PubMed Web of Science ®Google Scholar
• Gauczynski S, Hundt C, Leucht C, Weiss S. Interaction of prion proteins with cell surface receptors, molecular chaperones and other molecules. Adv Protein Chem 2001; 57:229 - 272
   PubMedGoogle Scholar
• DebBurman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997; 94:13938 - 13943
   PubMed Web of Science ®Google Scholar
• Edenhofer F, Rieger R, Famulok M, Wendler W, Weiss S, Winnacker EL. Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J Virol 1996; 70:4724 - 4728
   PubMed Web of Science ®Google Scholar
• Milhavet O, Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 2002; 38:328 - 339
   PubMed Web of Science ®Google Scholar
• Sandhu N, Duus K, Jorgensen CS, Hansen PR, Bruun SW, Pedersen LO, et al. Peptide binding specificity of the chaperone calreticulin. Biochim Biophys Acta 2007; 1774:701 - 713
   PubMed Web of Science ®Google Scholar
• Cohen E, Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A- treated cells. EMBO J 2003; 22:404 - 417
   PubMed Web of Science ®Google Scholar
• Ma J, Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 2001; 98:14955 - 14960
   PubMed Web of Science ®Google Scholar
• Deriziotis P, Tabrizi SJ. Prions and the proteasome. Biochim Biophys Acta 2008; 1782:713 - 722
   PubMed Web of Science ®Google Scholar
• Nieznanski K, Nieznanska H, Skowronek KJ, Osiecka KM, Stepkowski D. Direct interaction between prion protein and tubulin. Biochem Biophys Res Commun 2005; 334:403 - 411
   PubMed Web of Science ®Google Scholar
• Ganusova EE, Ozolins LN, Bhagat S, Newnam GP, Wegrzyn RD, Sherman MY, et al. Modulation of prion formation, aggregation and toxicity by the actin cytoskeleton in yeast. Mol Cell Biol 2006; 26:617 - 629
   PubMed Web of Science ®Google Scholar
• Martin SF, Herva ME, Espinosa JC, Parra B, Castilla J, Brun A, et al. Cell expression of a four extra octarepeat mutated PrPC modifies cell structure and cell cycle regulation. FEBS Lett 2006; 580:4097 - 4104
   PubMed Web of Science ®Google Scholar
• Silva JL, Lima LM, Foguel D, Cordeiro Y. Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem Sci 2008; 33:132 - 140
   PubMed Web of Science ®Google Scholar
• Rieger R, Edenhofer F, Lasmezas CI, Weiss S. The human 37 kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med 1997; 3:1383 - 1388
   PubMed Web of Science ®Google Scholar
• Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, et al. The 37 kDa/67 kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 2001; 20:5863 - 5875
   PubMed Web of Science ®Google Scholar
• Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC, et al. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 2005; 25:11330 - 11339
   PubMed Web of Science ®Google Scholar